ParagraphFour.com | gregoryglass | Activity https://paragraphfour.com/members/gregoryglass/activity/ Activity feed for gregoryglass. Fri, 01 May 2026 06:40:21 -0400 https://buddypress.org/?v= en-US 30 hourly 2 6f6ed6ec05737f7fd5b3186e2c51cef1 gregoryglass updated 'Xarelto®(rivaroxaban) Tablets ': Xarelto®(rivaroxaban) Tablets Annual Sales $2.36B (as […] https://paragraphfour.com/activity/p/11899/ Thu, 30 Apr 2026 22:12:48 -0400 Xarelto®(rivaroxaban) Tablets
Annual Sales $2.36B (as reported by J&J)
Company BAYER (JANSSEN)
Date of First Filing July 1, 2015 and November 15, 2018 (2.5mg)

Special Note 1: On 10/9/15, Bayer filed its PIV case against 7 ANDA filers (Aurobindo through Torrent). Bayer included all three patents against all of the defendants except where…Read more

]]> 0 cbc7015de52a56ce99216d3f37c76188 gregoryglass updated 'Jakafi®(ruxolitinib) Tablets ': Jakafi®(ruxolitinib) Tablets Annual Sales $2.79B Company […] https://paragraphfour.com/activity/p/11892/ Thu, 30 Apr 2026 21:04:32 -0400 Jakafi®(ruxolitinib) Tablets
Annual Sales $2.79B
Company INCYTE
Date of First Filing December 17, 2015

Special Note: After this product received its first PIV Notice in 2015, Incyte did not file any PIV cases until 2024 when a case against Apotex. We had placed this product as a “No Litigation Pending” product, and we keep that entry…Read more

]]> 0 ad5f3f9f254072b34cd29a95975fc870 gregoryglass updated 'Injectafer®(ferric carboxymaltose) Injection ': Injectafer®(ferric carboxymaltose) Injection Company VIFOR […] https://paragraphfour.com/activity/p/11891/ Thu, 30 Apr 2026 20:59:15 -0400 Injectafer®(ferric carboxymaltose) Injection
Company VIFOR INTERNATIONAL
Date of First Filing March 27, 2019 and February 22, 2024 (50 mg/10 mL)

Paragraph IV Applicant: Mylan
Case Name: VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD
Court/Case #: New Jersey District Court (njdc) 3:2019cv13955
Date Filed: 6/18/19
Judge: Wolfs…Read more

]]> 0 e29fb9197ad3781bb807fc61e727e6b8 gregoryglass updated 'Farxiga®(dapagliflozin) Tablets and dapagliflozin combination products ': Farxiga®(dapagliflozin) Tablets Xigduo […] https://paragraphfour.com/activity/p/11889/ Thu, 30 Apr 2026 20:06:00 -0400 Farxiga®(dapagliflozin) Tablets
Xigduo XR®(dapagliflozin/metformin) Extended-release Tablets
Qtern®(dapagliflozin/saxagliptin) Tablets
Company ASTRAZENECA
Product Sales: $1.75B
Date of First Filing January 8, 2018 (Farxiga); October 29, 2018 (Xigduo XR); July 29, 2020 (Qtern)

Special Note: After the sole case against Farxiga settled wi…Read more

]]> 0 b919e6bbdb4f116d5a06613be97336e0 gregoryglass updated 'Belrapzo®(bendamustine) Injection ': Belrapzo®(bendamustine) Injection Company EAGLE Date of […] https://paragraphfour.com/activity/p/11882/ Thu, 30 Apr 2026 18:32:19 -0400 Belrapzo®(bendamustine) Injection
Company EAGLE
Date of First Filing Not applicable/reported by FDA

Paragraph IV Applicant: Slayback
Case Name: EAGLE PHARMACEUICALS INC v. SLAYBACK PHARMA LLC
Court/Case #: Court of Appeals for the Federal Circuit (cafc) 19-1924
Date Filed: 5/24/19
Judge: O’Malley, Reyna, Chen
Product Strength:…Read more

]]> 0 0734247ca0264cc8efa0185ab0c59999 gregoryglass updated 'Adzenys XR- ODT®(amphetamine) ER ODT ': Adzenys XR- ODT®(amphetamine) Extended-release Orally […] https://paragraphfour.com/activity/p/11881/ Thu, 30 Apr 2026 18:24:53 -0400 Adzenys XR- ODT®(amphetamine) Extended-release Orally Disintegrating Tablets
Company NEOS THERAPEUTICS
Date of First Filing May 10, 2016

Paragraph IV Applicant: Actavis
Case Name: NEOS THERAPEUTICS INC et al v. ACTAVIS LABORATORIES FL INC et al
Court/Case #: Delaware District Court (dedc) 1:2016cv00766
Date Filed: 9/1/16
Judge:
Produc…Read more

]]> 0 fadda50ab09f274888c20d5f62ec5108 gregoryglass updated 'Vasostrict®(vasopressin) Injection ': Vasostrict®(vasopressin) Injection Company PAR Date of […] https://paragraphfour.com/activity/p/11880/ Wed, 29 Apr 2026 19:08:31 -0400 Vasostrict®(vasopressin) Injection
Company PAR
Date of First Filing March 23, 2018 (20 units/mL, 1 mL) and June 29, 2018 (20 units/mL, 10 mL) and February 28, 2022 (40 units/100 mL and 60 units/100 mL) and December 20, 2022 (20 units/100 mL)

Paragraph IV Applicant: Eagle
Case Name: PAR PHARMACEUTICAL INC et al v. EAGLE PHARMACEUTICALS,…Read more

]]> 0 79bb1c468537f085d256b633947073fb gregoryglass updated 'Invega Sustenna®(paliperidone) ER Inj Suspension ': Invega Sustenna®(paliperidone) Extended-release Injectable […] https://paragraphfour.com/activity/p/11863/ Wed, 29 Apr 2026 14:55:14 -0400 Invega Sustenna®(paliperidone) Extended-release Injectable Suspension
Annual Sales $3.1B (product family)
Company JANSSEN
Date of First Filing November 21, 2017

Paragraph IV Applicant: Teva
Case Name: JANSSEN PHARMACEUTICALS INC et al v. TEVA PHARMACEUTICALS USA INC et al
Court/Case #: Court of Appeals for the Federal Circuit (cafc)…Read more

]]> 0 b80374f5d799acacc0596a76de6ebbed gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11855/ Tue, 28 Apr 2026 14:24:33 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 0a0df52d6bae9ebd2b3dd02a560b1382 gregoryglass updated 'Xarelto®(rivaroxaban) Tablets ': Xarelto®(rivaroxaban) Tablets Annual Sales $2.36B (as […] https://paragraphfour.com/activity/p/11854/ Tue, 28 Apr 2026 14:23:39 -0400 Xarelto®(rivaroxaban) Tablets
Annual Sales $2.36B (as reported by J&J)
Company BAYER (JANSSEN)
Date of First Filing July 1, 2015 and November 15, 2018 (2.5mg)

Special Note 1: On 10/9/15, Bayer filed its PIV case against 7 ANDA filers (Aurobindo through Torrent). Bayer included all three patents against all of the defendants except where…Read more

]]> 0 15f7455851860b988cf784d475d532dd gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11852/ Sat, 25 Apr 2026 14:48:13 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 50c07935a0b27dde522e352f6c16c4b3 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11849/ Thu, 23 Apr 2026 17:10:31 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 7064ba5e9b6c9b3e6e8167aa7f2e4982 gregoryglass updated 'Bromsite(r)(bromfenac) Ophthalmic Solution ': Bromsite(r)(bromfenac) Ophthalmic Solution  Company SUN […] https://paragraphfour.com/activity/p/11848/ Thu, 23 Apr 2026 17:09:12 -0400 Bromsite(r)(bromfenac) Ophthalmic Solution 
Company SUN
Date of First Filing October 25, 2017

Paragraph IV Applicant: Lupin
Case Name: SUN PHARMA GLOBAL FZE et al v. LUPIN LIMITED et al
Court/Case #: New Jersey District Court (njdc) 3:2018cv02213
Date Filed: 2/15/18
Judge: Wolfson
Product Strength: 0.075%
Litigated Patents…Read more

]]> 0 4fa8e48371d739713f67529652deb22f gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11845/ Tue, 21 Apr 2026 20:08:44 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 6be446b180bc636cac4ef36366f63f4e gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11843/ Tue, 21 Apr 2026 19:49:12 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 e0a03c22f246227ce87b9bfb16628b82 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11842/ Tue, 21 Apr 2026 19:48:41 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 804fd3de7bea3ce8d5ebbac494aab81f gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11841/ Tue, 21 Apr 2026 19:47:43 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 f5ff90cfcb287f1d08aa427fbdbe8d08 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11839/ Fri, 17 Apr 2026 17:35:00 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 8048a19e9857ae82ade66f91e27624ef gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11837/ Fri, 17 Apr 2026 17:00:08 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 6e15884e87624c6c0ff12aea09034259 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11834/ Tue, 14 Apr 2026 15:03:46 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 72b9501bbd8270ba72436cc6c33c3217 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11832/ Tue, 14 Apr 2026 14:47:43 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 a99ffcc30d76a5fb538e708c1a6a3881 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11828/ Mon, 13 Apr 2026 14:54:29 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 0f3d4763e0cc1e275980b1cff094968c gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11826/ Mon, 13 Apr 2026 14:51:37 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 c4a80a3ce7a3c46603649b97480e5f70 gregoryglass updated 'Janumet XR®(sitagliptin and metformin) ER Tabs ': Janumet XR®(sitagliptin and metformin) Extended Release […] https://paragraphfour.com/activity/p/11825/ Mon, 13 Apr 2026 14:50:50 -0400 Janumet XR®(sitagliptin and metformin) Extended Release Tablets
Annual Sales
Company MERCK
Date of First Filing March 16, 2012 (50mg/500mg and 50mg/1,000mg) and October 22, 2012 (100mg/1,000mg)

Special Note: When the ANDA filer(s) filed their ANDA’s, Merck did not bring any PIV actions. As such, this product topic was listed as a “N…Read more

]]> 0 80fd12ccf2052aed42c1436fb8f725c8 gregoryglass updated 'Synjardy®(empagliflozin/met…) Tabs and XR® ': Synjardy®(empagliflozin and metformin) Tablets Synjardy […] https://paragraphfour.com/activity/p/11823/ Mon, 13 Apr 2026 14:36:15 -0400 Synjardy®(empagliflozin and metformin) Tablets
Synjardy XR®(empagliflozin and metformin) Extended-release Tablets
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the monotherapy product Jardiance®(empagliflozin) Tablets and combination therapy Gl…Read more

]]> 0 913feb4ce28b5dacdef201eae931c0f2 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11822/ Mon, 13 Apr 2026 14:34:42 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 dd3c07ca576b87aff04e24b78fdbb3dd gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11821/ Mon, 13 Apr 2026 14:32:40 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 02bc238b5c80fb1b8db5c35d8c2be5a5 gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11820/ Mon, 13 Apr 2026 14:27:24 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 f5a2af8d526905f1022bb1e921dd9c28 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11819/ Mon, 13 Apr 2026 14:22:10 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 298d897186567b47549b1182837b851e gregoryglass updated 'Glyxambi®(empagliflozin and linagliptin) Tablets ': Glyxambi®(empagliflozin and linagliptin) Tablets Company BOE […] https://paragraphfour.com/activity/p/11818/ Mon, 13 Apr 2026 14:16:38 -0400 Glyxambi®(empagliflozin and linagliptin) Tablets
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the monotherapy product Jardiance®(empagliflozin) Tablets as well as combination products Synjardy®(empagliflozin and metformin) Tablets and Synjardy XR…Read more

]]> 0 ce71b1eb4b9af435f8cb979adeb8aba3 gregoryglass updated 'Jardiance®(empagliflozin) Tablets ': Jardiance®(empagliflozin) Tablets Annual Sales $1.6B […] https://paragraphfour.com/activity/p/11817/ Mon, 13 Apr 2026 14:07:03 -0400 Jardiance®(empagliflozin) Tablets
Annual Sales $1.6B (product family) (as reported by Eli Lilly)
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me…Read more

]]> 0 d3aa59f74b922aa5acf94f2e1b4c3d11 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11816/ Sat, 11 Apr 2026 11:48:43 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 11d999fd19af71eb673ea28e0b93eb32 gregoryglass updated 'Trokendi XR®(topiramate) Extended-release Capsules ': Trokendi XR®(topiramate) Extended-release Capsules Company […] https://paragraphfour.com/activity/p/11813/ Thu, 09 Apr 2026 15:02:29 -0400 Trokendi XR®(topiramate) Extended-release Capsules
Company SUPERNUS
Date of First Filing April 3, 2014 (200mg) and May 12, 2014 (25, 50, and 100mg)

Paragraph IV Applicant: Actavis
Case Name: SUPERNUS PHARAMCEUTICALS INC v. ACTAVIS INC et al
Court/Case #: New Jersey District Court (njdc) 2:2014cv06102
Date Filed: 10/1/14
Judge: Wigento…Read more

]]> 0 94d9b8334057b94898fda5d12487fdb9 gregoryglass updated 'Rytary®(carbidopa and levodopa) ER Capsules ': Rytary®(carbidopa and levodopa) Extended-release […] https://paragraphfour.com/activity/p/11811/ Thu, 09 Apr 2026 14:53:19 -0400 Rytary®(carbidopa and levodopa) Extended-release Capsules
Company IMPAX LABS
Date of First Filing June 10, 2015 (61.25 mg/245 mg) and June 24, 2015 (23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg)

Paragraph IV Applicant: Actavis
Case Name: IMPAX LABORATORIES INC v. ACTAVIS LABORATORIES FL INC et al
Court/Case #: New Jersey District…Read more

]]> 0 3ebc1a4a63742b466521e2c05f564538 gregoryglass updated 'Lumigan®(bimatoprost) Ophthalmic Solution ': Lumigan®(bimatoprost) Ophthalmic Solution Company ALLERGAN […] https://paragraphfour.com/activity/p/11808/ Thu, 09 Apr 2026 14:42:37 -0400 Lumigan®(bimatoprost) Ophthalmic Solution
Company ALLERGAN
Date of First Filing December 22, 2008 (0.03%) and April 5, 2011 (0.01%)

Paragraph IV Applicant: Barr
Case Name: ALLERGAN INC. v. BARR LABORATORIES INC.
Court/Case #: Court of Appeals for the Federal Circuit (cafc) 12-1040
Date Filed: 10/21/2011
Judge: Wallach, Rader,…Read more

]]> 0 8068725a8a3ca6ff8efb5c744fbdefb0 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11806/ Thu, 09 Apr 2026 14:35:49 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 acf4783debb5fa3c3b86da218b7d331b gregoryglass updated 'Generic Companies Report #2 (F-P) ': The Paragraph Four Report ® Generic Companies Report #2 […] https://paragraphfour.com/activity/p/11805/ Thu, 09 Apr 2026 14:35:08 -0400 The Paragraph Four Report ®
Generic Companies Report #2 (F-P)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 05c28ed01a690fe11c9c033d91f77289 gregoryglass updated 'Branded Companies Report ': The Paragraph Four Report ® Branded Companies […] https://paragraphfour.com/activity/p/11804/ Thu, 09 Apr 2026 14:34:00 -0400 The Paragraph Four Report ®
Branded Companies Report

List of Companies with Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1, 2003)

ABBOTT LAB…Read more

]]> 0 15bb4382de00e4bb35149f81248723ec gregoryglass updated 'Colcrys®(colchicine) Tablets ': Colcrys®(colchicine) Tablets Company MUTUAL Date of […] https://paragraphfour.com/activity/p/11802/ Thu, 09 Apr 2026 14:28:01 -0400 Colcrys®(colchicine) Tablets
Company MUTUAL
Date of First Filing N/A (West Ward case) and December 23, 2011

Paragraph IV Applicant: West-Ward
Case Name: MUTUAL PHARMACEUTICAL COMPANY, INC. et al v. WEST-WARD PHARMACEUTICAL CORPORATION
Court/Case #: New Jersey District Court (njdc) 3:2011cv02276
Date Filed: 4/21/11
Judge: Cooper
Pro…Read more

]]> 0 3883142537e3c6b5872e486b9af5f52c gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11801/ Thu, 09 Apr 2026 14:25:46 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 406f4d2b6ecb5a3c018d547b1b563de9 gregoryglass updated 'Clenpiq®(sodium picosulfate, et al) Oral Solution ': Clenpiq®(sodium picosulfate, magnesium oxide and anhydrous […] https://paragraphfour.com/activity/p/11800/ Thu, 09 Apr 2026 14:25:12 -0400 Clenpiq®(sodium picosulfate, magnesium oxide and anhydrous citric acid) Oral Solution 
Company FERRING
Date of First Filing February 11, 2019

Paragraph IV Applicant: Lupin
Case Name: FERRING PHARMACEUTICALS INC et al v. LUPIN INC et al
Court/Case #: Delaware District Court (dedc) 1:2019cv00913
Date Filed: 5/16/19
Judge: Andrews
Produc…Read more

]]> 0 ff71e260ca91d95bd6a5fa879adcfe5e gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11799/ Tue, 07 Apr 2026 14:52:43 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 be5075b270b3f65dac19670bd5eccfa4 gregoryglass updated 'Omidria®(phenylephrine and ketorolac) Injection ': Omidria®(phenylephrine and ketorolac) Injection Company OMER […] https://paragraphfour.com/activity/p/11798/ Tue, 07 Apr 2026 14:51:54 -0400 Omidria®(phenylephrine and ketorolac) Injection
Company OMEROS
Date of First Filing May 29, 2015

Paragraph IV Applicant: Par
Case Name: OMEROS CORPORATION v. PAR STERILE PRODUCTS LLC et al
Court/Case #: Delaware District Court (dedc) 1:2015cv00773
Date Filed: 9/3/15
Judge: Andrews
Product Strength: 1%/0.3%
Litigated Patents…Read more

]]> 0 959b3a17d3bdd2d82fd24273e52106a8 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11797/ Tue, 07 Apr 2026 14:37:53 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 b6984dc78a4eb44a824adefb39c50c94 gregoryglass updated 'Jardiance®(empagliflozin) Tablets ': Jardiance®(empagliflozin) Tablets Annual Sales $1.6B […] https://paragraphfour.com/activity/p/11796/ Tue, 07 Apr 2026 14:37:10 -0400 Jardiance®(empagliflozin) Tablets
Annual Sales $1.6B (product family) (as reported by Eli Lilly)
Company BOEHRINGER INGELHEIM
Date of First Filing August 1, 2018

Special Note: When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me…Read more

]]> 0 f66fdb1f72a6dcc43c3f06ba218fb6aa gregoryglass updated 'Generic Companies Report #1 (A-E) ': The Paragraph Four Report ® Generic Companies Report #1 […] https://paragraphfour.com/activity/p/11795/ Tue, 07 Apr 2026 12:06:38 -0400 The Paragraph Four Report ®
Generic Companies Report #1 (A-E)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 08d1dfb8364a8e35c803bc9956e6d25e gregoryglass updated 'Abraxane®(paclitaxel) For Injection Suspension ': Abraxane®(paclitaxel) For Injection Suspension Company ABRAX […] https://paragraphfour.com/activity/p/11794/ Tue, 07 Apr 2026 12:06:04 -0400 Abraxane®(paclitaxel) For Injection Suspension
Company ABRAXIS
Date of First Filing December 11, 2015

Paragraph IV Applicant: Actavis
Case Name: ABRAXIS BIOSCIENCE LLC et al v. ACTAVIS LLC
Court/Case #: New Jersey District Court (njdc) 2:2016cv01925
Date Filed: 4/6/16
Judge: Vazquez
Product Strength: 100 mg/vial
Litigated Patents…Read more

]]> 0 26baae5eda492e6ac19390eb5a17c308 gregoryglass updated 'Generic Companies Report #3 (Q-Z) ': The Paragraph Four Report ® Generic Companies Report #3 […] https://paragraphfour.com/activity/p/11792/ Tue, 07 Apr 2026 11:46:11 -0400 The Paragraph Four Report ®
Generic Companies Report #3 (Q-Z)

List of Companies and Products under active Paragraph IV Certification
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an “Old Case” (terminated after November 1,…Read more

]]> 0 e6cdf98de81096f4492123e1512abcfb gregoryglass updated 'Last Month’s Paragraph IV Highlights ': March 2026 https://paragraphfour.com/activity/p/11789/ Thu, 02 Apr 2026 19:12:55 -0400 March 2026

]]> 0 6ec21275e435ce437111d5abb7336ac0 gregoryglass updated 'Myrbetriq®(mirabegron) Extended-release Tablets ': Myrbetriq®(mirabegron) Extended-release Tablets Annual […] https://paragraphfour.com/activity/p/11773/ Wed, 01 Apr 2026 15:54:36 -0400 Myrbetriq®(mirabegron) Extended-release Tablets
Annual Sales
Company ASTELLAS
Date of First Filing June 28, 2016

Special Summary Note #1: In 2016, Astellas brought PIV actions against 9 ANDA filers as listed below. By October 2020, all of the parties settled these original cases. On 11/24/20, the USPTO issued a new patent (10,842,780,…Read more

]]> 0